Few more questions :
- How are we similar/different from a Medidata for example.
- What has changed in the last 2/3 years in the life-sciences division market – both externally and internally which has made us in the fray for larger deal sizes – USD 20-25 MN
- Competition in this space should be heating up given the market growth and application of technology. What will enable Take to sustain and rather grow its position in the market.
I think the metrics to track in Take, like in MPS are
- Revenue share from Top 5/10 customers. That should consistently grow. I understand that this is going to be a increase wallet share with customer story rather than new customer addition story
| Subscribe To Our Free Newsletter |
